Concepedia

N. Harbeck

NH

6

Publications

184

Citations

6

H-Index

1998

Active since

Affiliations

Ludwig-Maximilians-Universität München(Current)

Olgahospital

Klinikum rechts der Isar

N. Harbeck is an author at Ludwig-Maximilians-Universität München specializing in tumor biology, cancer research, and pathology.

Top concepts

Publications per year

1998–2012

6

Publications

6

Application of intrathecal trastuzumab (Herceptin™) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer

Hans‐Joachim Stemmler, Mark R. Schmitt, N. Harbeck et al. · Oncology Reports · 2006 · 78 citations · Full text

Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.

Christoph Thomssen, Peter Oppelt, F. Jänicke et al. · PubMed · 1998 · 31 citations

, , +13

Study participation improves treatment strategies and individual patient care in participating centers.

Wolfgang Janni, Marion Kiechle, H. Sommer et al. · PubMed · 2006 · 25 citations

Clinical Relevance of Matrix Metalloproteinase-13 Determined with a New Highly Specific and Sensitive ELISA in Ascitic Fluid of Advanced Ovarian Carcinoma Patients

Bernd Hantke, N. Harbeck, Barbara Schmalfeldt et al. · Biological Chemistry · 2003 · 21 citations

BIBW 2992, a novel irreversible EGFR/HER1 and HER2 tyrosine kinase inhibitor, for the treatment of patients with HER2-negative metastatic breast cancer after failure of no more than two prior chemotherapies.

Martin Schüler, M. M. Uttenreuther-Fischer, Martine Piccart et al. · Journal of Clinical Oncology · 2010 · 17 citations

, , +14

Rows per page

1–5 of 6